The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | Common | 00287Y109 | 11,708 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
AbbVie Inc. | Common | 00287Y109 | 65,015 | 1,110,614 | SH | SOLE | 1,110,614 | 0 | 0 | ||
Accelerate Diagnostics, Inc | Common | 00430H102 | 3,254 | 144,625 | SH | SOLE | 144,625 | 0 | 0 | ||
Accuray, Inc. | Common | 004397105 | 6,807 | 731,943 | SH | SOLE | 731,943 | 0 | 0 | ||
Achillion Pharmaceuticals Inc. | Common | 00448Q201 | 5,396 | 547,300 | SH | SOLE | 547,300 | 0 | 0 | ||
Achillion Pharmaceuticals Inc. | Common | 00448Q201 | 5,396 | 547,300 | SH | Call | SOLE | 547,300 | 0 | 0 | |
Acorda Therapeutics, Inc. | Common | 00484M106 | 22,659 | 680,862 | SH | SOLE | 680,862 | 0 | 0 | ||
Actavis plc | Shares | G0083B108 | 107,645 | 361,686 | SH | SOLE | 361,686 | 0 | 0 | ||
Actavis plc | Preferred Convertible Series A | G0083B116 | 5,060 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Common | 00767E102 | 5,391 | 206,000 | SH | SOLE | 206,000 | 0 | 0 | ||
Aetna, Inc. | Common | 00817Y108 | 35,361 | 331,931 | SH | SOLE | 331,931 | 0 | 0 | ||
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 9,458 | 100,300 | SH | SOLE | 100,300 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 40,359 | 849,482 | SH | SOLE | 849,482 | 0 | 0 | ||
Alere, Inc. | Common | 01449J105 | 14,567 | 297,901 | SH | SOLE | 297,901 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 13,379 | 77,200 | SH | Call | SOLE | 77,200 | 0 | 0 | |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 87,049 | 502,305 | SH | SOLE | 502,305 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 35,879 | 588,470 | SH | SOLE | 588,470 | 0 | 0 | ||
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 21,267 | 1,778,200 | SH | SOLE | 1,778,200 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 5,670 | 54,300 | SH | Call | SOLE | 54,300 | 0 | 0 | |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 13,595 | 130,195 | SH | SOLE | 130,195 | 0 | 0 | ||
Amgen, Inc. | Common | 031162100 | 56,232 | 351,779 | SH | SOLE | 351,779 | 0 | 0 | ||
Athenahealth, Inc. | Common | 04685W103 | 2,758 | 23,100 | SH | Call | SOLE | 23,100 | 0 | 0 | |
Athenahealth, Inc. | Common | 04685W103 | 2,758 | 23,100 | SH | SOLE | 23,100 | 0 | 0 | ||
Baxter International, Inc. | Common | 071813109 | 21,893 | 319,600 | SH | SOLE | 319,600 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 1,390 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | Common | 09060J106 | 2,625 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Biogen Idec, Inc. | Common | 09062X103 | 5,151 | 12,200 | SH | Call | SOLE | 12,200 | 0 | 0 | |
Biogen Idec, Inc. | Common | 09062X103 | 143,343 | 339,483 | SH | SOLE | 339,483 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 66,669 | 534,977 | SH | SOLE | 534,977 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 6,585 | 54,527 | SH | SOLE | 54,527 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Common | 110122108 | 34,523 | 535,240 | SH | SOLE | 535,240 | 0 | 0 | ||
Catamaran Corporation | Common | 148887102 | 25,817 | 433,600 | SH | SOLE | 433,600 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 229,964 | 1,994,834 | SH | SOLE | 1,994,834 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADS | 15117K103 | 1,384 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 8,483 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
Cigna Corp | Common | 125509109 | 9,611 | 74,251 | SH | SOLE | 74,251 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 2,614 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
Community Health Systems, Inc. | Common | 203668108 | 10,956 | 209,572 | SH | SOLE | 209,572 | 0 | 0 | ||
Corsicanto Ltd. | Note 3.5% 1/15/32 | 220480AB3 | 15,656 | 14,700,000 | PRN | SOLE | 14,700,000 | 0 | 0 | ||
Eleven Biotherapeutics, Inc. | Common | 286221106 | 1,748 | 195,964 | SH | SOLE | 195,964 | 0 | 0 | ||
Endo International PLC | Shares | G30401106 | 22,584 | 251,773 | SH | SOLE | 251,773 | 0 | 0 | ||
Endologix Inc. | Common | 29266S106 | 9,406 | 551,000 | SH | SOLE | 551,000 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 3,756 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Flex Pharma, Inc. | Common | 33938A105 | 4,559 | 232,600 | SH | SOLE | 232,600 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 42,206 | 430,100 | SH | Call | SOLE | 430,100 | 0 | 0 | |
Gilead Sciences, Inc. | Common | 375558103 | 223,710 | 2,279,731 | SH | SOLE | 2,279,731 | 0 | 0 | ||
HCA Holdings, Inc. | Common | 40412C101 | 11,096 | 147,488 | SH | SOLE | 147,488 | 0 | 0 | ||
Health Care REIT Inc. | Common | 42217K601 | 13,432 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Heron Therapeutics, Inc. | Common | 427746102 | 12,716 | 873,940 | SH | SOLE | 873,940 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 8,692 | 56,265 | SH | SOLE | 56,265 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 5,458 | 29,400 | SH | Call | SOLE | 29,400 | 0 | 0 | |
Illumina, Inc. | Common | 452327109 | 24,735 | 133,241 | SH | SOLE | 133,241 | 0 | 0 | ||
Immunomedics, Inc. | Common | 452907108 | 1,915 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 16,155 | 344,683 | SH | SOLE | 344,683 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 5,133 | 56,000 | SH | Call | SOLE | 56,000 | 0 | 0 | |
Incyte Corporation | Common | 45337C102 | 85,836 | 936,461 | SH | SOLE | 936,461 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | Common | 45665G303 | 6,132 | 438,623 | SH | SOLE | 438,623 | 0 | 0 | ||
IntelliPharmaCeutics International Inc. | Common | 458173101 | 3,889 | 1,394,000 | SH | SOLE | 1,394,000 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 3,582 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
Ironwood Pharmaceuticals, Inc. | Common | 46333X108 | 12,289 | 768,050 | SH | SOLE | 768,050 | 0 | 0 | ||
Ishares Nasdaq Biotechnology ETF | ETF | 464287556 | 19,806 | 57,670 | SH | SOLE | 57,670 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 20,863 | 120,741 | SH | SOLE | 120,741 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 43,722 | 434,612 | SH | SOLE | 434,612 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | Common | 48576U106 | 14,600 | 476,966 | SH | SOLE | 476,966 | 0 | 0 | ||
Kite Pharma, Inc. | Common | 49803L109 | 2,682 | 46,500 | SH | Call | SOLE | 46,500 | 0 | 0 | |
Kite Pharma, Inc. | Common | 49803L109 | 2,682 | 46,500 | SH | SOLE | 46,500 | 0 | 0 | ||
KYTHERA Biopharmaceuticals Inc | Common | 501570105 | 2,794 | 55,717 | SH | SOLE | 55,717 | 0 | 0 | ||
LTC Properties Inc. | Common | 502175102 | 10,884 | 236,618 | SH | SOLE | 236,618 | 0 | 0 | ||
Macrogenics, Inc. | Common | 556099109 | 400 | 12,743 | SH | SOLE | 12,743 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 15,350 | 67,862 | SH | SOLE | 67,862 | 0 | 0 | ||
Medical Properties Trust Inc. | Common | 58463J304 | 17,004 | 1,153,574 | SH | SOLE | 1,153,574 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 10,634 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | 2,929 | 1,485,000 | PRN | SOLE | 1,485,000 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 6,745 | 567,787 | SH | SOLE | 567,787 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 23,410 | 347,901 | SH | SOLE | 347,901 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 5,374 | 353,575 | SH | SOLE | 353,575 | 0 | 0 | ||
Mylan NV | Shares Euro | N59465109 | 59,950 | 1,010,105 | SH | SOLE | 1,010,105 | 0 | 0 | ||
Myriad Genetics, Inc. | Shares Euro | 62855J104 | 2,648 | 74,800 | SH | Call | SOLE | 74,800 | 0 | 0 | |
Myriad Genetics, Inc. | Common | 62855J104 | 2,648 | 74,800 | SH | SOLE | 74,800 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 19,901 | 501,150 | SH | SOLE | 501,150 | 0 | 0 | ||
Omega Healthcare Investors Inc. | Common | 681936100 | 16,760 | 413,116 | SH | SOLE | 413,116 | 0 | 0 | ||
OncoGenex Pharmaceuticals, Inc. | Common | 68230A106 | 243 | 113,100 | SH | SOLE | 113,100 | 0 | 0 | ||
Perrigo Company plc | Common | G97822103 | 11,208 | 67,700 | SH | Call | SOLE | 67,700 | 0 | 0 | |
Perrigo Company plc | Shares | G97822103 | 21,629 | 130,652 | SH | SOLE | 130,652 | 0 | 0 | ||
Pfizer, Inc. | Common | 717081103 | 56,994 | 1,638,241 | SH | SOLE | 1,638,241 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 18,506 | 1,050,902 | SH | SOLE | 1,050,902 | 0 | 0 | ||
Receptos, Inc. | Common | 756207106 | 20,578 | 124,800 | SH | SOLE | 124,800 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 84,502 | 187,166 | SH | SOLE | 187,166 | 0 | 0 | ||
Sabra Health Care REIT Inc. | Common | 78573L106 | 15,123 | 456,190 | SH | SOLE | 456,190 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 753 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 9,521 | 409,500 | SH | SOLE | 409,500 | 0 | 0 | ||
Sangamo BioSciences, Inc. | Common | 800677106 | 10,648 | 679,100 | SH | SOLE | 679,100 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 1,529 | 115,100 | SH | Call | SOLE | 115,100 | 0 | 0 | |
Sarepta Therapeutics, Inc. | Common | 803607100 | 3,058 | 230,300 | SH | SOLE | 230,300 | 0 | 0 | ||
Senior Housing Properties Trust | Shares | 81721M109 | 10,642 | 479,604 | SH | SOLE | 479,604 | 0 | 0 | ||
Sorrento Therapeutics, Inc. | Common | 83587F202 | 1,648 | 142,597 | SH | SOLE | 142,597 | 0 | 0 | ||
Spectrum Pharmaceuticals, Inc. | Note 2.75% 12/15/18 | 84763AAB4 | 4,572 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
St Jude Medical, Inc. | Common | 790849103 | 10,563 | 161,510 | SH | SOLE | 161,510 | 0 | 0 | ||
Stryker Corporation | Common | 863667101 | 11,433 | 123,940 | SH | SOLE | 123,940 | 0 | 0 | ||
Supernus Pharmaceuticals, Inc. | Note 7.50% 5/1/19 | 868459AB4 | 4,826 | 2,000,000 | PRN | SOLE | 2,000,000 | 0 | 0 | ||
Synageva BioPharma Corp | Common | 87159A103 | 6,925 | 71,000 | SH | Call | SOLE | 71,000 | 0 | 0 | |
Synageva BioPharma Corp | Common | 87159A103 | 19,378 | 198,689 | SH | SOLE | 198,689 | 0 | 0 | ||
Tenet Healthcare Corp | Common | 88033G407 | 2,946 | 59,500 | SH | SOLE | 59,500 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 62,150 | 997,594 | SH | SOLE | 997,594 | 0 | 0 | ||
TherapeuticsMD, Inc. | Common | 88338N107 | 8,963 | 1,481,500 | SH | SOLE | 1,481,500 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 19,035 | 141,695 | SH | SOLE | 141,695 | 0 | 0 | ||
TrovaGene, Inc. | Common | 897238309 | 4,427 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
Ventas Inc. | Common | 92276F100 | 21,379 | 292,782 | SH | SOLE | 292,782 | 0 | 0 | ||
Verastem, Inc. | Common | 92337C104 | 12,711 | 1,249,827 | SH | SOLE | 1,249,827 | 0 | 0 | ||
Vertex Pharmaceuticals, Inc. | Common | 92532F100 | 54,767 | 464,244 | SH | SOLE | 464,244 | 0 | 0 | ||
WellCare Health Plans Inc. | Common | 94946T106 | 8,108 | 88,652 | SH | SOLE | 88,652 | 0 | 0 | ||
Wright Medical Group Inc. | Common | 98235T107 | 4,027 | 156,100 | SH | SOLE | 156,100 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 306 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Zafgen, Inc. | Common | 98885E103 | 527 | 13,307 | SH | SOLE | 13,307 | 0 | 0 | ||
Zimmer Holdings, Inc. | Common | 98956P102 | 12,022 | 102,300 | SH | SOLE | 102,300 | 0 | 0 | ||
Zogenix, Inc. | Common | 98978L105 | 3,906 | 2,850,811 | SH | SOLE | 2,850,811 | 0 | 0 |